Similar articles for PMID: 31291180

Year	Number of Results
1992	1
1997	1
1999	1
2001	2
2002	1
2004	2
2006	4
2008	2
2009	2
2011	3
2012	6
2013	12
2014	5
2015	3
2016	7
2017	19
2018	26
2019	16
2020	12
2021	9
2022	10
2023	10
2024	0

1

Giant cell arteritis: An updated review of an old disease.

Rinden T, Miller E, Nasr R. Rinden T, et al. Cleve Clin J Med. 2019 Jul;86(7):465-472. doi: 10.3949/ccjm.86a.18103. Cleve Clin J Med. 2019. PMID: 31291180 Free article. Review.

2

[Clinical and biological efficacy of tocilizumab in giant cell arteritis: report of three patients and literature review].

Kieffer P, Hinschberger O, Ciobanu E, Jaeger-Bizet F, Drabo A, Mostoufizadeh T, Martzolff L. Kieffer P, et al. Rev Med Interne. 2014 Jan;35(1):56-9. doi: 10.1016/j.revmed.2012.12.012. Epub 2013 Sep 26. Rev Med Interne. 2014. PMID: 24075627 Review. French.

3

Tocilizumab in Giant Cell Arteritis.

Mariano VJ, Frishman WH. Mariano VJ, et al. Cardiol Rev. 2018 Nov/Dec;26(6):321-330. doi: 10.1097/CRD.0000000000000204. Cardiol Rev. 2018. PMID: 29570475 Review.

4

[Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?].

Samson M, Bonnotte B. Samson M, et al. Rev Med Interne. 2018 Feb;39(2):75-77. doi: 10.1016/j.revmed.2017.11.003. Epub 2017 Dec 6. Rev Med Interne. 2018. PMID: 29217104 French. No abstract available.

5

[Efficacy and tolerance of tocilizumab for corticosteroid sparing in giant cell arteritis and aortitis: Experience of Nimes University Hospital about eleven patients].

Broner J, Arnaud E. Broner J, et al. Rev Med Interne. 2018 Feb;39(2):78-83. doi: 10.1016/j.revmed.2017.11.001. Epub 2017 Dec 6. Rev Med Interne. 2018. PMID: 29221884 French.

6

Tocilizumab in the treatment of giant cell arteritis.

Leuchten N, Aringer M. Leuchten N, et al. Immunotherapy. 2018 Mar 1;10(6):465-472. doi: 10.2217/imt-2017-0182. Epub 2018 Mar 5. Immunotherapy. 2018. PMID: 29504436 Review.

7

Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis.

Palmowski A, Buttgereit F. Palmowski A, et al. Curr Rheumatol Rep. 2020 Oct 12;22(12):85. doi: 10.1007/s11926-020-00961-0. Curr Rheumatol Rep. 2020. PMID: 33047263 Free PMC article. Review.

8

Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients.

Régent A, Redeker S, Deroux A, Kieffer P, Ly KH, Dougados M, Liozon E, Larroche C, Guillevin L, Bouillet L, Espitia O, Costedoat-Chalumeau N, Soubrier M, Brihaye B, Lifermann F, Lefevre G, Puéchal X, Mouthon L, Toussirot E; French Vasculitis Group, the Groupe Francais pour l’Etude de l’Artérite à Cellules Géantes, and the Club Rhumatismes et Inflammation. Régent A, et al. J Rheumatol. 2016 Aug;43(8):1547-52. doi: 10.3899/jrheum.151252. Epub 2016 May 15. J Rheumatol. 2016. PMID: 27182063

9

Trial of Tocilizumab in Giant-Cell Arteritis.

Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schett G, Schulze-Koops H, Spiera R, Unizony SH, Collinson N. Stone JH, et al. N Engl J Med. 2017 Jul 27;377(4):317-328. doi: 10.1056/NEJMoa1613849. N Engl J Med. 2017. PMID: 28745999 Free article. Clinical Trial.

10

Giant Cell Arteritis: Beyond Corticosteroids.

Steel L, Khan A, Dasgupta B. Steel L, et al. Drugs Aging. 2015 Aug;32(8):591-9. doi: 10.1007/s40266-015-0284-7. Drugs Aging. 2015. PMID: 26239828 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

129 results

Results by year